RecruitingPhase 1NCT07786779

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Profile of YKYY033 Injection

A Phase I, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Profile of YKYY033 Injection in Chinese Healthy Adult Participants

Sponsor

Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.

Enrollment

40 participants

Start Date

Jul 10, 2026

Study Type

INTERVENTIONAL

Conditions

Venous Thromboembolism (VTE)

Summary

A phase 1 study to evaluate the safety and tolerability of a single administration of YKYY033 injection in healthy adult participants

Eligibility

Min Age: 18 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called YKYY033 Injection and a drug called YKYY033 Placebo for people with venous thromboembolism (vte). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGYKYY033 Injection

subcutaneous injection, a single subcutaneous injection of the corresponding dose of YKYY033 injection

DRUGYKYY033 Placebo

subcutaneous injection, a single subcutaneous injection of the corresponding dose of YKYY033 Placebo

Locations(1)

Peking University Third Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07786779

Related Trials

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

NCT0701590546 locations

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

NCT074933042 locations

Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis

NCT071402118 locations

Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism

NCT071435396 locations

Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk

NCT0684542318 locations